Crossmark

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s13195-018-0418-3

Published Online: 2018-08-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lewczuk, Piotr https://orcid.org/0000-0002-8101-6535
Gaignaux, Amélie

Kofanova, Olga

Ermann, Natalia

Betsou, Fay

Brandner, Sebastian

Mroczko, Barbara

Blennow, Kaj

Strapagiel, Dominik

Paciotti, Silvia

Vogelgsang, Jonathan

Roehrl, Michael H.

Mendoza, Sandra

Kornhuber, Johannes

Teunissen, Charlotte
Funding

Funding for this research was provided by:

Innovative Medicines Initiative Joint Undertaking (EMIF grant agreement n° 115372)

NIH/NCI Cancer Center Support (P30 CA008748)

Polish Ministry of Science and Higher Education (DIR/WK/2017/01)
License Information

Text and Data Mining valid from 2018-08-28
More Information

Article History

Received: 26 April 2018

Accepted: 31 July 2018

First Online: 28 August 2018

Ethics approval and consent to participate

: This study does not use or report any samples or data of individual subjects, and hence ethical consent is not applicable.

: Not applicable.

: PL received consultation and/or lecture honoraria from IBL International, Fujirebio Europe, AJ Roboscreen, and Roche. CT functioned in advisory boards of Fujirebio and Roche, received nonfinancial support in the form of research consumables from ADxNeurosciences and Euroimmun, and performed contract research or received grants from Probiodrug, Janssen Prevention Ca enter, Boehringer, Brainsonline, AxonNeurosciences, EIP farma, and Roche.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.